4/16
A closer look at the role of health care algorithms in racial and ethnic disparities
A closer look at the role of health care algorithms in racial and ethnic disparities
A Penn Medicine study points to ways to reduce potential for racial bias and inequity when using algorithms to inform clinical care.
$55M gift creates new ‘Cancer Interception’ Institute at Penn’s Basser Center for BRCA to stop hereditary cancers at the earliest stages
$55M gift creates new ‘Cancer Interception’ Institute at Penn’s Basser Center for BRCA to stop hereditary cancers at the earliest stages
Funding for the Institute from Mindy and Jon Gray will propel early detection and prevention of breast, ovarian, pancreatic, and prostate cancers.
Future-Proofing Penn Medicine: University of Pennsylvania Announces $1.5 Billion Hospital Pavilion
The University of Pennsylvania will build a $1.5 billion new hospital on Penn Medicine’s West Philadelphia campus.
Tweeting the Way to Health: Penn Medicine Launches Center for Digital Health
Across the world, social media users leave a trail of clues about themselves each time they Tweet, post to Facebook, write a Yelp review, and apply a filter and hashtags to their latest Instagram photo. Under the leadership of Raina Merchant, MD, MSHP, researchers and physicians at Penn Medicine are mining those clues to find what ails them – and how to fix it.
Novartis-Penn Center for Advanced Cellular Therapeutics Unveiled at Penn Medicine
Physicians, scientists and leaders from the University of Pennsylvania’s Perelman School of Medicine and the global pharmaceutical company Novartis will gather Tuesday evening to unveil the Novartis-Penn Center for Advanced Cellular Therapeutics (CACT).
Penn Researchers Report Sustained Remission After Treatment with Investigational Personalized Cellular Therapy In Patient with Multiple Myeloma
A multiple myeloma patient whose cancer had stopped responding after nine different treatment regimens experienced a complete remission after receiving an investigational personalized cellular therapy known as CTL019 developed by a team at the University of Pennsylvania.
Dean of Penn’s Perelman School of Medicine: Precision Medicine is “Personalized, Problematic, and Promising”
The rapidly emerging field of precision medicine is a “disruptive innovation” that offers the possibility of remarkably fine-tuned remedies to improve patient health while minimizing the risk of harmful side effects, says J. Larry Jameson, MD, PhD, dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System, in this week’s issue of the New England Journal of Medicine.
Penn Medicine Immunotherapy Pioneer Carl June, MD, Awarded 2015 Paul Ehrlich and Ludwig Darmstaedter Prize
University of Pennsylvania cancer and HIV expert Carl June, MD, has been named one of two recipients of the 2015 Paul Ehrlich and Ludwig Darmstaedter Prize for his outstanding work in cancer immunotherapy.